Chao Tung Wen
Direktor/Vorstandsmitglied bei TATUNG SYSTEM TECHNOLOGIES INC.
Profil
Chao Tung Wen is an Independent Director at Tatung System Technologies, Inc. and a Professor at National Chengchi University.
He previously held positions as Chairman at Eastern Ad, and as an Independent Director at E Ink Holdings, Inc. and PharmaDax Inc. Dr. Wen holds an MBA from the University of Rochester, a doctorate from Rensselaer Polytechnic Institute, and an undergraduate degree from Tunghai University.
Aktive Positionen von Chao Tung Wen
| Unternehmen | Position | Beginn |
|---|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Direktor/Vorstandsmitglied | 24.06.2013 |
| National Chengchi University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Chao Tung Wen
| Unternehmen | Position | Ende |
|---|---|---|
| E INK HOLDINGS INC. | Direktor/Vorstandsmitglied | - |
| Eastern Ad | Vorsitzender | - |
| PHARMADAX INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Chao Tung Wen
| Tunghai University | Undergraduate Degree |
| Rochester Christian University | Masters Business Admin |
| Rensselaer Polytechnic Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TATUNG SYSTEM TECHNOLOGIES INC. | Commercial Services |
| E INK HOLDINGS INC. | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| Eastern Ad |
